254 related articles for article (PubMed ID: 10982614)
1. Relation between K-ras codon 12 mutation and p53 protein overexpression in gallbladder cancer and biliary ductal epithelia in patients with pancreaticobiliary maljunction.
Masuhara S; Kasuya K; Aoki T; Yoshimatsu A; Tsuchida A; Koyanagi Y
J Hepatobiliary Pancreat Surg; 2000; 7(2):198-205. PubMed ID: 10982614
[TBL] [Abstract][Full Text] [Related]
2. p53 gene mutation and p53 protein overexpression in a patient with simultaneous double cancer of the gallbladder and bile duct associated with pancreaticobiliary maljunction.
Kasuya K; Nagakawa Y; Matsudo T; Ozawa T; Tsuchida A; Aoki T; Itoi T; Itokawa F
J Hepatobiliary Pancreat Surg; 2009; 16(3):376-81. PubMed ID: 19183832
[TBL] [Abstract][Full Text] [Related]
3. K-ras point mutations in cancerous and noncancerous biliary epithelium in patients with pancreaticobiliary maljunction.
Matsubara T; Sakurai Y; Sasayama Y; Hori H; Ochiai M; Funabiki T; Matsumoto K; Hirono I
Cancer; 1996 Apr; 77(8 Suppl):1752-7. PubMed ID: 8608574
[TBL] [Abstract][Full Text] [Related]
4. Pancreaticobiliary maljunction and carcinogenesis to biliary and pancreatic malignancy.
Funabiki T; Matsubara T; Miyakawa S; Ishihara S
Langenbecks Arch Surg; 2009 Jan; 394(1):159-69. PubMed ID: 18500533
[TBL] [Abstract][Full Text] [Related]
5. Clinical and genetic analysis of noncancerous and cancerous biliary epithelium in patients with pancreaticobiliary maljunction.
Nagai M; Watanabe M; Iwase T; Yamao K; Isaji S
World J Surg; 2002 Jan; 26(1):91-8. PubMed ID: 11898040
[TBL] [Abstract][Full Text] [Related]
6. Biliary carcinogenesis in pancreaticobiliary maljunction.
Kamisawa T; Kuruma S; Chiba K; Tabata T; Koizumi S; Kikuyama M
J Gastroenterol; 2017 Feb; 52(2):158-163. PubMed ID: 27704265
[TBL] [Abstract][Full Text] [Related]
7. Proliferative potential and K-ras mutation in epithelial hyperplasia of the gallbladder in patients with anomalous pancreaticobiliary ductal union.
Tanno S; Obara T; Fujii T; Mizukami Y; Shudo R; Nishino N; Ura H; Klein-Szanto AJ; Kohgo Y
Cancer; 1998 Jul; 83(2):267-75. PubMed ID: 9669809
[TBL] [Abstract][Full Text] [Related]
8. p53 gene mutations and overexpression of p53 product in cancerous and noncancerous biliary epithelium in patients with pancreaticobiliary maljunction.
Matsubara T; Funabiki T; Jinno O; Sakurai Y; Hasegawa S; Imazu H; Ochiai M
J Hepatobiliary Pancreat Surg; 1999; 6(3):286-93. PubMed ID: 10526065
[TBL] [Abstract][Full Text] [Related]
9. K-ras and p53 mutations in stage I gallbladder carcinoma with an anomalous junction of the pancreaticobiliary duct.
Hanada K; Itoh M; Fujii K; Tsuchida A; Ooishi H; Kajiyama G
Cancer; 1996 Feb; 77(3):452-8. PubMed ID: 8630951
[TBL] [Abstract][Full Text] [Related]
10. High expression of karyopherin-α2 and stathmin 1 is associated with proliferation potency and transformation in the bile duct and gall bladder epithelia in the cases of pancreaticobiliary maljunction.
Saito F; Araki K; Yokobori T; Ishii N; Tsukagoshi M; Watanabe A; Kubo N; Altan B; Shirabe K; Kuwano H
J Surg Oncol; 2016 Sep; 114(4):462-8. PubMed ID: 27338241
[TBL] [Abstract][Full Text] [Related]
11. Point mutations of the c-Ki-ras gene in carcinoma and atypical epithelium associated with congenital biliary dilation.
Tomono H; Nimura Y; Aono K; Nakashima I; Iwamoto T; Nakashima N
Am J Gastroenterol; 1996 Jun; 91(6):1211-4. PubMed ID: 8651173
[TBL] [Abstract][Full Text] [Related]
12. Pancreaticobiliary maljunction: pathophysiological and clinical aspects and the impact on biliary carcinogenesis.
Matsumoto Y; Fujii H; Itakura J; Matsuda M; Yang Y; Nobukawa B; Suda K
Langenbecks Arch Surg; 2003 Apr; 388(2):122-31. PubMed ID: 12684801
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in pancreaticobiliary maljunction.
Matsumoto Y; Fujii H; Itakura J; Matsuda M; Nobukawa B; Suda K
J Hepatobiliary Pancreat Surg; 2002; 9(1):45-54. PubMed ID: 12021897
[TBL] [Abstract][Full Text] [Related]
14. Gene mutations of K-ras in gallbladder mucosae and gallbladder carcinoma with an anomalous junction of the pancreaticobiliary duct.
Hanada K; Tsuchida A; Iwao T; Eguchi N; Sasaki T; Morinaka K; Matsubara K; Kawasaki Y; Yamamoto S; Kajiyama G
Am J Gastroenterol; 1999 Jun; 94(6):1638-42. PubMed ID: 10364037
[TBL] [Abstract][Full Text] [Related]
15. IL-33 overexpression in gallbladder cancers associated with pancreatobiliary maljunction.
Tomioka Y; Sung YN; Sawada R; Hong SM; Akita M; Itoh T; Ajiki T; Fukumoto T; Zen Y
Histopathology; 2019 Sep; 75(3):365-375. PubMed ID: 30882917
[TBL] [Abstract][Full Text] [Related]
16. Surgical strategy for patients with pancreaticobiliary maljunction without choledocal dilatation.
Funabiki T; Matsubara T; Ochiai M; Marugami Y; Sakurai Y; Hasegawa S; Imazu H
Keio J Med; 1997 Dec; 46(4):169-72. PubMed ID: 9444927
[TBL] [Abstract][Full Text] [Related]
17. Double cancer of gall bladder and bile duct not associated with anomalous junction of the pancreaticobiliary duct system.
Hori H; Ajiki T; Fujita T; Okazaki T; Suzuki Y; Kuroda Y; Fujimori T
Jpn J Clin Oncol; 2006 Oct; 36(10):638-42. PubMed ID: 16908513
[TBL] [Abstract][Full Text] [Related]
18. Analysis of c-Ki-ras oncogene and p53 immunocytochemistry in the gallbladder mucosa of an experimental dog model of anomalous arrangement of the pancreaticobiliary ducts.
Sasaki K; Kunitomo K; Yagi K; Masamune K; Komi N; Tashiro S
Tokushima J Exp Med; 1996 Dec; 43(3-4):101-6. PubMed ID: 9100457
[TBL] [Abstract][Full Text] [Related]
19. Importance of early diagnosis of pancreaticobiliary maljunction without biliary dilatation.
Takuma K; Kamisawa T; Tabata T; Hara S; Kuruma S; Inaba Y; Kurata M; Honda G; Tsuruta K; Horiguchi S; Igarashi Y
World J Gastroenterol; 2012 Jul; 18(26):3409-14. PubMed ID: 22807610
[TBL] [Abstract][Full Text] [Related]
20. K-ras and p53 gene mutations in noncancerous biliary lesions of patients with pancreaticobiliary maljunction.
Matsubara T; Sakurai Y; Zhi LZ; Miura H; Ochiai M; Funabiki T
J Hepatobiliary Pancreat Surg; 2002; 9(3):312-21. PubMed ID: 12353142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
